甲状旁腺功能亢进

jiǎ zhuàng páng xiàn gōng néng kàng jìn
  • hyperparathyroidism
甲状旁腺功能亢进甲状旁腺功能亢进
  1. 核医学技术在原发性甲状旁腺功能亢进中的应用

    The application of nuclear medical technology in primary hyperparathyroidism

  2. 18例原发性甲状旁腺功能亢进症的诊治分析

    Analysis of Diagnosis and Treatment of Primary Hyperparathyroidism

  3. 目的研究肾性甲状旁腺功能亢进(甲旁亢)患者甲状旁腺组织钙敏感受体(CaR)的表达,探讨CaR在肾性甲旁亢发病机制中的作用。

    Objective TO study the expression of calcium sensing receptor ( CaR ) protein in parathyroid tissue of uremic secondary hyperparathyroidism ( SHPT ) .

  4. 小剂量1,25(OH)2D3口服冲击治疗尿毒症患者继发性甲状旁腺功能亢进

    Pulse therapy of low dose oral 1,25 ( OH ) 2D 3 in uremic patients with second hyperparathyroidism

  5. ~(99m)Tc-MIBI双时相显像对继发性甲状旁腺功能亢进的临床价值

    Clinical value of dual-phase ~ ( 99m ) Tc-MIBI scintigraphy in secondary hyperparathyroidism

  6. 目的:了解慢性肾功能衰竭继发性甲状旁腺功能亢进症(简称慢性肾衰继发性甲旁亢)患者对红细胞生成素(EPO)疗效的影响。

    Objective : To explore the effect of erythropoietin ( EPO ) on patients of chronic renal failure with hyperparathyroidism .

  7. 目的评价阿法迪三犤1α-(OH)-D3犦每日或冲击治疗血液透析患者继发性甲状旁腺功能亢进(甲旁亢)的有效性和安全性。

    Objective To investigate the efficacy and safety of a treatment protocol involving alfacalcidol ( 1 α ( OH ) D3 ) pulse versus daily therapy in treating secondary hyperparathyroidism in maintenance hemodialysis patients .

  8. 目为探讨α骨化醇(1α-(OH)D3,霜叶红)治疗慢性肾衰引起继发性甲状旁腺功能亢进的疗效。

    Objective To investigate the effects of oral 1 a - ( OH ) D3 on secondary hyperparathyroidism in chronic renal failure patients with dialysis or non - dialysis .

  9. 新生儿严重甲状旁腺功能亢进症:基因型/表现型间相关性和应用pamidronate作为抢救措施

    Neonatal severe hyperparathyroidism : Genotype / phenotype correlation and the use of pamidronate as rescue therapy

  10. 弥漫性摄取见于四肢、胸、腹部(淋巴和B或静脉回流障碍120例,恶性胸、腹腔积液各146及44例,甲状旁腺功能亢进3例,肝脏转移瘤20例);

    Diffuse accumulations were detected in limbs , chest and abdomen ( malignant pleural effusion , 146 , malignant seroperitoneum , 44 , obstruction in circumfluence of vein or lymph , 120 , hyperparathyroidism , 3 , metastatic tumor in liver , 20 ) .

  11. 目的评价原发性甲状旁腺功能亢进症(HPT)99mTc-MIBI双时相显像的病灶定位诊断的价值。

    Objective To evaluate the diagnostic value of localization of primary hyperparathyroidism with ~ ( 99m ) Tc-MIBI double-phase SPECT Imaging .

  12. 结论99mTc-MIBI显像对原发性甲状旁腺功能亢进症的诊断敏感性高,尤其是腺瘤,其检测敏感性与高血清PTH水平相一致,类似于剂量依赖方式。

    Visualization of hyperfunctioning parathyroid glands on 99mTc-MIBI parathyroid scintigraphy was more likely with a higher serum PTH level in a dose-dependent manner .

  13. 该指南侧重于无症状性原发性甲状旁腺功能亢进症,即缺乏高血钙或PTH过量引起的相关特征性症状或体征的原发性甲状旁腺功能亢进症。

    This Workshop was focused upon asymptomatic PHPT , a condition defined as hyperparathyroidism that lacks specific symptoms or signs traditionally associated with hypercalcemia or PTH excess .

  14. 结论:活性维生素D3治疗可明显改善维持性血透患者的左心室肥厚,此作用与其改变继发性甲状旁腺功能亢进有关。

    Conclusions : The 1.25-dihydroxyvitamin D 3 treatment can improve LVH significantly in MHD patients , and it may be due to the improvement of secondary hyperparathyroidism .

  15. 目的了解99mTc-MIBI显像在原发性甲状旁腺功能亢进症患者的诊断价值及与甲状旁腺素(PTH)放射免疫分析的关系。

    Objective To evaluate the diagnostic value of 99mTc-MIBI parathyroid imaging and the relation between 99mTc-MIBI imaging and parathyroid hormone ( PTH ) in primary hyperparathyroidism .

  16. 目的探讨血液透析(HD)对慢性肾功衰竭(CRF)病人钙磷代谢紊乱及继发甲状旁腺功能亢进(SHPT)的作用。

    Objective To investigate the effects of hemodialysis ( HD ) on the disorders of calcium phosphate metabolism and secondary hyperparathyroidism ( SHPT ) in patients with chronic renal failure ( CRF ) .

  17. 目的:了解高频彩超、CT、99mTc甲氧基异丁基异晴(MIBI)双时相平面显像核医学对尿毒症继发性甲状旁腺功能亢进(SHPT)患者甲状旁腺检查的敏感性和特异性。

    Objective : To investigate the sensitivities and specificities of high-frequency color doppler ultrasonography , thin layer CT enhancing scan and 99m Tc-MIBI biphasic scintigraphy in diagnosis of secondary hyperparathyroidism ( SHPT ) in uremia patients .

  18. 血清PTH-M测定诊断271例慢性肾衰致继发性甲状旁腺功能亢进

    Clinical application of serum PTH m determination in diagnosis of secondary hyperparathyroidism induced by chronic renal failure

  19. 目的探讨围手术期处理对三发性甲状旁腺功能亢进症(THPT)治疗效果的影响。

    [ Objective ] To examine the therapeutic effects of perioperative management for tertiary hyperparathyroidism ( THPT ) .

  20. 甲状旁腺功能亢进性骨病误诊为骨肿瘤1例并文献复习

    One Case Report about Misdiagnosis of Primary Hyperparathyroidism and Literatures Review

  21. 表现为消化道症状的甲状旁腺功能亢进二例

    Hyperparathyroidism present with digestive tract symptom : two cases report

  22. 骨化三醇冲击治疗血液透析患者继发性甲状旁腺功能亢进的疗效

    Effects of calcitriol pulse therapy in patients with secondary hyperparathyroidism undergoing hemodialysis

  23. 常规和冲击剂量的阿法D3治疗尿毒症继发性甲状旁腺功能亢进

    Routine and pulse dosage alpha d_3 therapy for uremia patients with secondary hyperparathyroidism

  24. 静脉注射和口服活性维生素D3治疗尿毒症性甲状旁腺功能亢进的多中心临床研究

    Effect of intravenous Calcijex on secondary uremic hyperparathyroidism : a multicenter clinical trial

  25. 阿法骨化醇治疗维持性血液透析患者继发甲状旁腺功能亢进41例

    Alfacalcidol Treating 41 Maintence Hemodialysis Patients with Secondary Hyperparathyroidism

  26. 结论高磷饮食可成功地建立适合影像学研究的原发性甲状旁腺功能亢进动物模型。

    Conclusion Animal model with primary hyperparathyroidism can be established by high-phosphate diet .

  27. 原发性甲状旁腺功能亢进症9例报告并文献复习

    Primary Hyperparathyroidism , a Study of Nine Cases and Review of the Literature

  28. 三种影像学检查方法对诊断继发性甲状旁腺功能亢进的意义

    Diagnosis value of secondary hyperparathyroidism with three imaging methods

  29. 如存在甲状旁腺功能亢进,就需行甲状旁腺增生或腺瘤切除。

    If hyperparathyroidism is present , removal of hyperplastic or adenomatous parathyroids is required .

  30. 由一长期误诊病例谈原发性甲状旁腺功能亢进症的诊治

    Discussion about the diagnosis and treatment of primary hyperparathyroidism from a long-term misdiagnosed case